Am Heart J

1. VERGHESE D, Hamal S, Ghanem A, Kinninger A, et al
   Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients with STable CoROnary Artery Disease CoMpared to Placebo (EKSTROM) Trial - Rationale and Design.
   Am Heart J. 2024 Jul 17:S0002-8703(24)00171-6. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   

   
   Am J Cardiol

2. JI SS, Zhao LX, Chen W, Wang YF, et al
   The Characteristics of Coronary Artery Lesions in COVID-19 Infected Patients with Coronary Artery Disease:An Optical Coherence Tomography Study.
   Am J Cardiol. 2024 Jul 13:S0002-9149(24)00514.
   

   >> Share

   
   
3. DE OLIVEIRA PP, Abelin AP, Machado GP, Filho EM, et al
   Evaluation of success and complications scores for chronic total occlusion percutaneous coronary interventions: insights from the LATAM registry.
   Am J Cardiol. 2024 Jul 17:S0002-9149(24)00540.
   

   >> Share

   
   
4. RYABOV V, Dil S, Vyshlov E, Mochula O, et al
   <>.
   Am J Cardiol. 2024 Jul 16:S0002-9149(24)00542.
   

   >> Share

   
   

   
   Am J Emerg Med

5. ANAND AB, Gitte PT, Sabnis GR, Mahajan AU, et al
   ECG manifestations of occlusion of septal perforator of left anterior descending artery.
   Am J Emerg Med. 2024;82:42-46.
   

   >> Share

   
   
6. HYUN JH, Park SH, Kim K
   How to determine the focus of emergent medical care in healthcare policy: Proposal of treatable death.
   Am J Emerg Med. 2024;82:88-93.
   

   >> Share

   
   
7. LITTMANN L
   An unusual cause of giant T waves.
   Am J Emerg Med. 2024;82:215.
   

   >> Share

   
   

   
   Angiology

8. SHEN X, Jian W, Liu J
   Reply to Letter: The Use of Routine Blood Values as Diagnostic Parameters in Cardiovascular Diseases.
   Angiology. 2024 Jul 19:33197241265253. doi: 10.1177/00033197241265253.
   

   >> Share

   
   
9. OGUZ M, Akbulut T, Saylik F, Sipal A, et al
   Response to Comments on the Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study.
   Angiology. 2024 Jul 19:33197241264956. doi: 10.1177/00033197241264956.
   

   >> Share

   
   
10. WANG L, Wang P, Tang Z
    Letter: Modified Glasgow Prognostic Score as a New Biomarker for the Prognosis of Acute Coronary Syndrome Patients.
    Angiology. 2024 Jul 19:33197241263719. doi: 10.1177/00033197241263719.
    

    >> Share

    
    

    
    Ann Intern Med

11. KEPPEL S, Borzak S
    In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.
    Ann Intern Med. 2024;177:JC74.
    

    >> Share

    
    

    
    Ann Thorac Surg

12. JAMEIE M, Valinejad K, Pashang M, Jameie M, et al
    Impact of multi-arterial revascularization on long-term major adverse cardiovascular events after coronary bypass in 23,798 patients.
    Ann Thorac Surg. 2024 Jul 13:S0003-4975(24)00570.
    

    >> Share

    
    

    
    Atherosclerosis

13. OLIVEIRA-SANTOS M, Borges-Rosa J, Silva R, Paixao L, et al
    Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT.
    Atherosclerosis. 2024;395:117481.
    

    >> Share

    
    
14. MULLIS DM, Padilla-Lopez A, Wang H, Zhu Y, et al
    Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT/LDLR KO mouse.
    Atherosclerosis. 2024;395:117518.
    

    >> Share

    
    
15. PARK CH, Kim HW, Park JT, Chang TI, et al
    Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study.
    Atherosclerosis. 2024;395:117563.
    

    >> Share

    
    
16. HOSHINO M, Jukema RA, Pijls N, Hoek R, et al
    Microvascular resistance reserve before and after PCI: A serial FFR and [(15)O] H(2)O PET study.
    Atherosclerosis. 2024;395:117555.
    

    >> Share

    
    
17. BEN-SHABAT N, Krasun A, Fisher L, Patt YS, et al
    Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study.
    Atherosclerosis. 2024;396:117626.
    

    >> Share

    
    
18. QI X, Zhang Y, Wang Y, Sun J, et al
    Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
    Atherosclerosis. 2024;395:117552.
    

    >> Share

    
    
19. WENTZEL JJ, Bos D, White SJ, van der Heiden K, et al
    Sex-related differences in coronary and carotid vessel geometry, plaque composition and shear stress obtained from imaging.
    Atherosclerosis. 2024;395:117616.
    

    >> Share

    
    
20. PATEL NH, Dave EK, Fatade YA, De Cecco CN, et al
    Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
    Atherosclerosis. 2024;395:118520.
    

    >> Share

    
    
21. MIRANDA MARAVI JS, Leszczynski EC, Schwartz CS, Dev PK, et al
    Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.
    Atherosclerosis. 2024;395:117587.
    

    >> Share

    
    
22. ZHANG J, Zhong Q, Lin Y, Zhang Y, et al
    Longitudinal albuminuria patterns predict coronary artery calcification progression: Findings from the Coronary Artery Risk Development in Young Adults study.
    Atherosclerosis. 2024;395:117574.
    

    >> Share

    
    
23. FERRARO B
    The SR-B1DeltaCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
    Atherosclerosis. 2024;395:117564.
    

    >> Share

    
    

    
    Cardiovasc Res

24. KUFAZVINEI TTJ, Chai J, Boden KA, Channon KM, et al
    Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
    Cardiovasc Res. 2024 Jul 19:cvae142. doi: 10.1093.
    

    >> Share

    
    

    
    Circ Cardiovasc Imaging

25. SPERRY BW, Metzinger MP, Ibrahim AO, Thompson RC, et al
    Age- and Sex-Specific Myocardial Blood Flow Values in Patients Without Coronary Atherosclerosis on Rb-82 PET Myocardial Perfusion Imaging.
    Circ Cardiovasc Imaging. 2024;17:e016577.
    

    >> Share

    
    
26. DONG T, Cremer PC
    Myocardial Blood Flow in Patients Without Coronary Artery Disease: Slowing Down With Age.
    Circ Cardiovasc Imaging. 2024;17:e017138.
    

    >> Share

    
    
27. R SCARPA MATUCK B, Arbab-Zadeh A
    Predictors of Rapid Coronary Plaque Progression Measured by CT: More Opportunities to Optimize Prevention.
    Circ Cardiovasc Imaging. 2024;17:e017135.
    

    >> Share

    
    
28. RODRIGUEZ LOZANO PF, Hosadurg N
    Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?
    Circ Cardiovasc Imaging. 2024;17:e017136.
    

    >> Share

    
    
29. NEGLIA D, Caselli C, Maffei E, Cademartiri F, et al
    Rapid Plaque Progression Is Independently Associated With Hyperglycemia and Low HDL Cholesterol in Patients With Stable Coronary Artery Disease: A PARADIGM Study.
    Circ Cardiovasc Imaging. 2024;17:e016481.
    

    >> Share

    
    
30. MSZAR R, Cainzos-Achirica M, Valero-Elizondo J, Lahan S, et al
    Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.
    Circ Cardiovasc Imaging. 2024;17:e016152.
    

    >> Share

    
    
31. TORNVALL P, Beltrame JF, Nickander J, Sorensson P, et al
    How to Use Cardiac Magnetic Resonance Imaging in Myocardial Infarction With Nonobstructive Coronary Arteries.
    Circ Cardiovasc Imaging. 2024;17:e016463.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

32. MAQSOOD MH, Yong CM, Rao SV, Cohen MD, et al
    Procedural Outcomes With Femoral, Radial, Distal Radial, and Ulnar Access for Coronary Angiography: A Network Meta-Analysis.
    Circ Cardiovasc Interv. 2024 Jul 19:e014186.
    

    >> Share

    
    
33. HAN JK, Yang S, Hwang D, Park SH, et al
    Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial.
    Circ Cardiovasc Interv. 2024;17:e013585.
    

    >> Share

    
    
34. HAMILTON GW, Theuerle J, Chye D, Bhaskar J, et al
    Graft Patency and Clinical Outcomes in Patients With Radial Artery Grafts Previously Instrumented for Cardiac Catheterization.
    Circ Cardiovasc Interv. 2024;17:e013739.
    

    >> Share

    
    

    
    Circ Cardiovasc Qual Outcomes

35. MORROW DA, Jessup M, Abraham WT, Acker M, et al
    American Heart Association Cardiogenic Shock Registry: Design and Implementation.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010637.
    

    >> Share

    
    
36. STREED CG JR, Radix AE
    Prioritizing Patient Perspectives: Cardiovascular Health of Transgender and Nonbinary People.
    Circ Cardiovasc Qual Outcomes. 2024 Jul 18:e011319.
    

    >> Share

    
    
37. RYTZ CL, Pattar BSB, Mizen SJ, Lieb P, et al
    Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.
    Circ Cardiovasc Qual Outcomes. 2024 Jul 18:e011024.
    

    >> Share

    
    

    
    Circ Heart Fail

38. BHARDWAJ A, Munagala M
    Mixed Shock Complicating Cardiogenic Shock: A Corollary or a Ramification?
    Circ Heart Fail. 2024;17:e011902.
    

    >> Share

    
    
39. BALDETTI L, Gallone G, Filiberti G, Pescarmona L, et al
    Mixed Shock Complicating Cardiogenic Shock: Frequency, Predictors, and Clinical Outcomes.
    Circ Heart Fail. 2024;17:e011404.
    

    >> Share

    
    
40. TEN BERG S, Otterspoor L, Henriques JPS
    Letter by ten Berg et al Regarding Article, "Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network Registry".
    Circ Heart Fail. 2024;17:e011970.
    

    >> Share

    
    

    
    Circ Res

41. JAMA HA, Dona MSI, Dinakis E, Nakai M, et al
    Maternal Diet and Gut Microbiota Influence Predisposition to Cardiovascular Disease in Offspring.
    Circ Res. 2024 Jul 17. doi: 10.1161/CIRCRESAHA.124.324614.
    

    >> Share

    
    

    
    Circulation

42. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    

    >> Share

    
    
43. ADEDINSEWO D
    Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
    Circulation. 2024;150:174-176.
    

    >> Share

    
    
44. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2024;150:243-245.
    

    >> Share

    
    
45. WANG Y, Chen GC, Wang Z, Luo K, et al
    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
    Circulation. 2024;150:215-229.
    

    >> Share

    
    
46. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
    Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
    Circulation. 2024;150:250-252.
    

    >> Share

    
    

    
    Eur Heart J

47. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    

    >> Share

    
    
48. JURADO-ROMAN A, Agudo-Quilez P
    Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
    Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
    

    >> Share

    
    
49. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    

    >> Share

    
    

    
    Hypertension

50. LING Q, Dong X, Bai J, Deng Y, et al
    Impact of Hypertension Duration on the Cardiovascular Benefit of Intensive Blood Pressure Control.
    Hypertension. 2024 Jul 17. doi: 10.1161/HYPERTENSIONAHA.124.23439.
    

    >> Share

    
    
51. MUNTNER P, Jaeger BC, Foti K, Ghazi L, et al
    Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension.
    Hypertension. 2024 Jul 15. doi: 10.1161/HYPERTENSIONAHA.124.22998.
    

    >> Share

    
    

    
    Int J Cardiol

52. KOH SJQ, Jiang Y, Lau YH, Yip WLJ, et al
    Optimal door-to-balloon time for primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Int J Cardiol. 2024;413:132345.
    

    >> Share

    
    
53. FUJINO M, Aikawa H, Nakao K, Takagi K, et al
    Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis.
    Int J Cardiol. 2024 Jul 2:132329. doi: 10.1016/j.ijcard.2024.132329.
    

    >> Share

    
    
54. PROVENZALE G, Barbieri L, Tumminello G, Carugo S, et al
    Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection.
    Int J Cardiol. 2024;411:132285.
    

    >> Share

    
    
55. TILLER C, Reindl M, Lechner I, Reinstadler SJ, et al
    Circulating progenitor cells: A promising biomarker for coronary collateral formation in CTO?
    Int J Cardiol. 2024;411:132267.
    

    >> Share

    
    
56. GADAGER BB, Tang LH, Doherty P, Svendsen ML, et al
    Are cardiac rehabilitation pathways influenced by diabetes: A cohort study.
    Int J Cardiol. 2024;411:132275.
    

    >> Share

    
    

    
    J Am Coll Cardiol

57. EZAD SM, McEntegart M, Dodd M, Didagelos M, et al
    Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
    J Am Coll Cardiol. 2024;84:340-350.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

58. LINGYAN Z, Zijia H, Ya Z, Ying Z, et al
    Cardiovascular outcomes of SGLT-2 Inhibitors Across BMI Spectrum in Heart Failure Patients: An Updated Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2024 Jul 8. doi: 10.1097/FJC.0000000000001610.
    

    >> Share

    
    
59. SCIAHBASI A, De Rosa S, Gargiulo G, Giacoppo D, et al
    Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001607.
    

    >> Share

    
    
60. ZHANG J, Xiong X, Li J, Luo C, et al
    Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTbetaR to regulate MGA/MAX/c-Myc/Cx43.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001613.
    

    >> Share

    
    
61. HSIAO BY
    Sjogren syndrome and outcomes of acute myocardial infarction: A propensity-score matched analysis of the Nationwide Inpatient Sample 2005-2018.
    J Cardiovasc Pharmacol. 2024 Jun 19. doi: 10.1097/FJC.0000000000001603.
    

    >> Share

    
    
62. WRIGHT CX, Feher A
    From Risk to Resilience: improved outcomes after myocardial infarction in patients with Sjogren's syndrome.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001615.
    

    >> Share

    
    

    
    J Clin Epidemiol

63. HAGEMAN SHJ, Post RAJ, Visseren FLJ, McEvoy JW, et al
    Estimating uncertainty when providing individual cardiovascular risk predictions: A Bayesian survival analysis.
    J Clin Epidemiol. 2024 Jul 15:111464. doi: 10.1016/j.jclinepi.2024.111464.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

64. YI J, Chen K, Cao Y, Wen C, et al
    Up-regulated novel-miR-17 promotes hypothermic reperfusion arrhythmias by negatively targeting Gja1 and mediating activation of the PKC/c-Jun signaling pathway.
    J Mol Cell Cardiol. 2024;193:1-10.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

65. NGUYEN SN, Vinogradsky AV, Tao AM, Chung MM, et al
    Rare Coronary Artery Variants are Associated with Increased Mortality and Reinterventions Following the Arterial Switch Operation.
    J Thorac Cardiovasc Surg. 2024 Jul 12:S0022-5223(24)00611.
    

    >> Share

    
    

    
    Lancet

66. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    

    >> Share

    
    

    
    N Engl J Med

67. LI P
    FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
    N Engl J Med. 2024;391:287-288.
    

    >> Share

    
    
68. BOHM F, James S
    FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. Reply.
    N Engl J Med. 2024;391:288.
    

    >> Share

    
    

    
    PLoS One

69. HOLCK EN, Jakobsen L, Winther NS, Mogensen LJ, et al
    Long-term outcomes after revascularization in chronic total and non-total occluded coronary arteries: A regionwide cohort study.
    PLoS One. 2024;19:e0307264.
    

    >> Share

    
    
70. CHEN L, Dai L, Xu J, Duan L, et al
    Chinese herbal compound preparation Qing-Xin-Jie-Yu granules for intermediate coronary lesions in patients with stable coronary artery disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    PLoS One. 2024;19:e0307074.
    

    >> Share

    
    
71. YANG X, Huang Y, Tang D, Yue L, et al
    Identification of key genes associated with acute myocardial infarction using WGCNA and two-sample mendelian randomization study.
    PLoS One. 2024;19:e0305532.
    

    >> Share

    
    
72. SALET N, Gokdemir A, Preijde J, van Heck CH, et al
    Using machine learning to predict acute myocardial infarction and ischemic heart disease in primary care cardiovascular patients.
    PLoS One. 2024;19:e0307099.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

73. KRISHNAN S, Aldana-Bitar J, Golub I, Kianoush S, et al
    Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution.
    Prog Cardiovasc Dis. 2024 Jul 17:S0033-0620(24)00100.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share